The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma

O6-methylguanine-DNA-methyltransferase (MGMT) has emerged as a relevant predictor of therapeutic response and good prognosis in patients with glioblastoma (GBM). Transcriptionally active MGMT rapidly removes the alkyl adducts, preventing the formation of cross-links and thereby causing resistance to...

Descripción completa

Detalles Bibliográficos
Autores principales: Villani, Veronica, Casini, Beatrice, Pace, Andrea, Prosperini, Luca, Carapella, Carmine M., Vidiri, Antonello, Fabi, Alessandra, Carosi, Mariantonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548097/
https://www.ncbi.nlm.nih.gov/pubmed/26347581
http://dx.doi.org/10.1155/2015/604719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548097/
https://www.ncbi.nlm.nih.gov/pubmed/26347581
http://dx.doi.org/10.1155/2015/604719

Ejemplares similares